发明名称 Inhibitors of human tumor-expressed CCXCKR2
摘要 Pharmaceutical compositions containing organic compounds or salts thereof that serve as modulators for the SDF-1 or I-TAC chemokines are disclosed. The compounds and compositions are useful in the treatment of cancer, especially in the inhibition of cancer proliferation, growth, and metastasis. Methods of interfering with SDF-1 and/or I-TAC binding to the CCXCKR2 receptor and treating cancer using the compounds and pharmaceutical compositions of the present invention are also disclosed.
申请公布号 US7649011(B2) 申请公布日期 2010.01.19
申请号 US20030743281 申请日期 2003.12.22
申请人 CHEMOCENTRYX, INC. 发明人 MELIKIAN ANITA;BURNS JENNIFER;MCMASTER BRIAN E.;SCHALL THOMAS;WRIGHT J. J.
分类号 A61K31/541;A61K31/496;C07D207/06;C07D207/08;C07D207/09;C07D207/12;C07D207/14;C07D207/16;C07D211/14;C07D211/42;C07D211/56;C07D241/04;C07D241/42;C07D295/13;C07D401/04;C07D401/06;C07D405/04;C07D405/06;C07D405/12;C07D405/14;C07D417/02 主分类号 A61K31/541
代理机构 代理人
主权项
地址